期刊文献+

盐酸吡柔比星通过上调ATG4B增强HeLa细胞保护性自噬 被引量:2

Pirarubicin induces cytoprotective autophagy in HeLa cells through up-regulating autophapy related 4B
下载PDF
导出
摘要 目的探讨盐酸吡柔比星增强宫颈癌He La细胞自噬水平的可能机制。方法采用CCK-8检测盐酸吡柔比星单独或联用自噬抑制剂氯喹对He La细胞增殖的影响;台盼蓝染色实验检测盐酸吡柔比星单独或联用自噬抑制剂氯喹对He La细胞死亡的影响;GFP-LC3质粒转染He La细胞后观察盐酸吡柔比星对自噬小体形成的影响;Western blot检测细胞中自噬标志分子Ⅱ型微管相关蛋白轻链3(microtuble-associated protein light chain 3-Ⅱ,LC3-Ⅱ)、自噬相关分子自噬相关蛋白4B(autophapy related 4B,ATG4B)的表达情况。CCK-8实验及台盼蓝染色实验观察在有或者无自噬抑制剂氯喹作用下以及shRNA下调He La细胞中的ATG4B后盐酸吡柔比星对He La细胞的杀伤效应的影响。结果盐酸吡柔比星能剂量依赖地抑制He La细胞的增殖并促进其死亡(P<0.05);盐酸吡柔比星处理能显著增加He La细胞中自噬小体的数量,并显著上调自噬标志分子LC3-II、自噬关键酶ATG4B的表达;自噬抑制剂氯喹可显著增强盐酸吡柔比星的杀细胞效应(P<0.05),shRNA干扰ATG4B可抑制盐酸吡柔比星对He La细胞中自噬的增强作用(P<0.05),并增强盐酸吡柔比星的杀细胞效应(P<0.05)。结论盐酸吡柔比星通过上调ATG4B而增强的自噬对He La细胞起保护作用。 Objective To investigate the mechanism and significance of pirarubicin in enhancing the autophagy of He La cells. Methods Trypan blue exclusion assay and CCK-8 assay were used to detect cell mortality and proliferation in He La cells treated with different doses of pirarubicin alone or combined with chloroquine( autophagy inhibitor). The effect of pirarubicin on autophagosome formation in He La cells transfected with GFP-LC3 plasmid was observed with fluorescence microscopy. Western blotting was used to determine the protein levels of autophagy markers microtuble-associated protein light chain 3-Ⅱ( LC3-Ⅱ),and autophapy related 4B( ATG4B). After ATG4 B was down-regulated with shRNA in He La cells,the effect of pirarubicin on killing He La cells in the presence of chloroquine was observed. Results Pirarubicin inhibited cell proliferation and induced cell death in a dose-dependent manner in He La cells( P〈0. 05).Pirarubicin induced the formation of LC3-GFP puncta in He La cells,and increased the expression of LC3 Ⅱand ATG4 B markedly. Chloroquine enhanced pirarubicin-triggered cell death in He La cells( P〈0. 05).Knockdown of ATG4 B via shRNA suppressed pirarubicin-induced autophagy and increased pirarubicin-induced cell death in He La cells. Conclusion Pirarubicin induces cytoprotective autophagy in He La cells through upregulating ATG4 B.
出处 《第三军医大学学报》 CAS CSCD 北大核心 2016年第2期129-135,共7页 Journal of Third Military Medical University
基金 国家自然科学基金(81472436) 重庆市自然科学基金(CSTC2014jcyj A10110)~~
关键词 盐酸吡柔比星 自噬 自噬相关蛋白4B 宫颈癌 pirarubicin autophagy autophapy related 4B uterine cervical neoplasm
  • 相关文献

参考文献29

  • 1Ferlay J, Shin H R, Bray F, et al. Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008[J]. Int J Cancer, 2010, 127(12): 2893-2917. DOI:10.1002/ijc.25516.
  • 2Chauvergne J, Fumoleau P, Cappelaere P, et al. Phase II study of pirarubicin (THP) in patients with cervical, endometrial and ovarian cancer: study of the Clinical Screening Group of the European Organization for Research and Treatment of Cancer (EORTC)[J]. Eur J Cancer, 1993, 29A(3): 350-354.
  • 3李席如,王建东,张艳君,孔庆龙,马冰,李捷,郑一琼,陈玉秋,晋援朝,李荣.多西他赛联合表柔比星/比柔比星新辅助治疗乳腺癌临床分析[J].中华医学杂志,2009,89(2):87-90. 被引量:20
  • 4Untch M, Sevin B U, Perras J P, et al. Chemosensitivity to the new anthracycline pirarubicin and other chemotherapeutic agents in primary and recurrent ovarian tumors in vitro[J]. Gynecol Oncol, 1992, 47(2): 172-178.
  • 5Kato T, Nishimura H, Umezu J, et al. Phase II study of 4′-O-tetrahydropyranyl-adriamycin (THP-ADM) in patients with gynecological cancer[J]. Gan To Kagaku Ryoho, 1985, 12(10): 1962-1967.
  • 6Guo X L, Li D, Hu F, et al. Targeting autophagy potentiates chemotherapy-induced apoptosis and proliferation inhibition in hepatocarcinoma cells[J]. Cancer Lett, 2012, 320(2): 171-179. DOI:10.1016/j.canlet.2012.03.002.
  • 7Xu Y, Yu H, Qin H, et al. Inhibition of autophagy enhances cisplatin cytotoxicity through endoplasmic reticulum stress in human cervical cancer cells[J]. Cancer Lett, 2012, 314(2): 232-243. DOI:10.1016/j.canlet.2011.09.034.
  • 8Li K, Chen X, Liu C, et al. Pirarubicin induces an autophagic cytoprotective response through suppression of the mammalian target of rapamycin signaling pathway in human bladder cancer cells[J]. Biochem Biophys Res Commun, 2015, 460(2): 380-385. DOI:10.1016/j.bbrc.2015.03.042.
  • 9Tsukagoshi S. Pirarubicin (THP-adriamycin)[J]. Gan To Kagaku Ryoho, 1988, 15(9): 2819-2827.
  • 10Kaku S, Takahashi K, Murakami Y, et al. Neoadjuvant intraarterial chemotherapy for stage IIB-IIIB cervical cancer in Japanese women[J]. Exp Ther Med, 2010, 1(4): 651-655.

二级参考文献11

  • 1Garces CA, Cance WG. Neoadjuvant chemotherapy of breast cancer. Am Surg, 2004,70 : 565-569.
  • 2Charfare H, Limongelli S, Purushotham AD, et al. Neoadjuvant chemotherapy in breast cancer. Br J Surg,2005, 92:14-23.
  • 3Abrial SC, Penault-Llorca F, Delva R, et al. High prognostic significance of residual disease after neoadjuvant chemotherapy: a retrospective study in 710 patients with operable breast cancer. Breast Cancer Res Treat,2005, 94: 255-263.
  • 4Penault-Llorea F, Cayre A, Bouchet-Mishellany F, et al. Induction chemotherapy for breast carcinoma: predictive markers and relation with outcome. Int J Oncol,2003, 22: 1319-1325.
  • 5Petit T, Wilt M, Velten M, et al. Comparative value of tumor grade hormonal receptors, Ki 67, HER 2 and topoisomerase II alpha status as predictive markers in breast cancer patients treated with neoadjuvant anthracycline-based chemotherapy. Eur J Cancer, 2004,40 : 205 -211.
  • 6Gregory RK, Powles TJ, Salter J, et al. Prognostic relevance of CerhB2 expression following neoadjuvant chemotherapy in patients in a randomized trial of neoadjuvant versus adjuvant chemoendocrine therapy. Breast Cancer Res Treat, 2000,59 : 171 - 175.
  • 7Estevez LG, Guevas JM, Anton A, et al. Weekly docetaxel as neoadjuvant chemotherapy for stage II and III breast cancer: efficacy and correlation with biological markers in a phase II , muhicenter study. Clin Cancer Res,2003 ,9 :686-692.
  • 8Liedtke C, Mazouni C, Hess KR, et al. Response to neoadjuvant therapy and long-term survival in patients with triple-negative breast cancer. J Clin Oncol,2008 26 : 1275-1281.
  • 9Carey LA, Dees EC ,Sawyer L, et al. The triple negative paradox: primary tumor chemosensitivity of breast cancer subtypes. Clin Cancer Res ,2007,13:2329-2334.
  • 10Honkoop AH, Luykx-de Bakker SA, Hoekman K, et al. Prolonged neoadjuvant chemotherapy with GM-CSF in locally advanced breast cancer. Oncologist, 1999,4 : 106-111.

共引文献23

同被引文献13

引证文献2

二级引证文献6

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部